全文获取类型
收费全文 | 383108篇 |
免费 | 15280篇 |
国内免费 | 901篇 |
专业分类
耳鼻咽喉 | 3300篇 |
儿科学 | 12030篇 |
妇产科学 | 7248篇 |
基础医学 | 46450篇 |
口腔科学 | 6599篇 |
临床医学 | 32179篇 |
内科学 | 74708篇 |
皮肤病学 | 4431篇 |
神经病学 | 36276篇 |
特种医学 | 17212篇 |
外国民族医学 | 51篇 |
外科学 | 58662篇 |
综合类 | 4714篇 |
现状与发展 | 2篇 |
一般理论 | 216篇 |
预防医学 | 33222篇 |
眼科学 | 6997篇 |
药学 | 24124篇 |
2篇 | |
中国医学 | 1029篇 |
肿瘤学 | 29837篇 |
出版年
2023年 | 996篇 |
2022年 | 1686篇 |
2021年 | 3791篇 |
2020年 | 2562篇 |
2019年 | 3691篇 |
2018年 | 25813篇 |
2017年 | 20274篇 |
2016年 | 22798篇 |
2015年 | 5377篇 |
2014年 | 7020篇 |
2013年 | 9683篇 |
2012年 | 19971篇 |
2011年 | 34244篇 |
2010年 | 26544篇 |
2009年 | 18865篇 |
2008年 | 31494篇 |
2007年 | 34461篇 |
2006年 | 13537篇 |
2005年 | 15237篇 |
2004年 | 15910篇 |
2003年 | 16050篇 |
2002年 | 13738篇 |
2001年 | 3883篇 |
2000年 | 3714篇 |
1999年 | 3696篇 |
1998年 | 3138篇 |
1997年 | 2533篇 |
1996年 | 2116篇 |
1995年 | 2024篇 |
1994年 | 1768篇 |
1993年 | 1747篇 |
1992年 | 2264篇 |
1991年 | 2251篇 |
1990年 | 2065篇 |
1989年 | 1986篇 |
1988年 | 1717篇 |
1987年 | 1708篇 |
1986年 | 1580篇 |
1985年 | 1524篇 |
1984年 | 1347篇 |
1983年 | 1232篇 |
1982年 | 1230篇 |
1981年 | 1145篇 |
1980年 | 1018篇 |
1979年 | 996篇 |
1978年 | 772篇 |
1977年 | 764篇 |
1976年 | 645篇 |
1975年 | 680篇 |
1974年 | 682篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
142.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
143.
144.
145.
Birgitta Malmberg Göran Kecklund Björn Karlson Roger Persson Per Flisberg Palle Ørbaek 《BMC health services research》2010,10(1):239
Background
It is well known that physicians' night-call duty may cause impaired performance and adverse effects on subjective health, but there is limited knowledge about effects on sleep duration and recovery time. In recent years occupational stress and impaired well-being among anaesthesiologists have been frequently reported for in the scientific literature. Given their main focus on handling patients with life-threatening conditions, when on call, one might expect sleep and recovery to be negatively affected by work, especially in this specialist group. The aim of the present study was to examine whether a 16-hour night-call schedule allowed for sufficient recovery in anaesthesiologists compared with other physician specialists handling less life-threatening conditions, when on call. 相似文献146.
David Berrigan Linda W Pickle Jennifer Dill 《International journal of health geographics》2010,9(1):20
Background
Past studies of associations between measures of the built environment, particularly street connectivity, and active transportation (AT) or leisure walking/bicycling have largely failed to account for spatial autocorrelation of connectivity variables and have seldom examined both the propensity for AT and its duration in a coherent fashion. Such efforts could improve our understanding of the spatial and behavioral aspects of AT. We analyzed spatially identified data from Los Angeles and San Diego Counties collected as part of the 2001 California Health Interview Survey. 相似文献147.
Sebastiana Z. Kalula G. H. Swingler A. A. Sayer M. Badri M. Ferreira 《The journal of nutrition, health & aging》2010,14(4):319-323
Objective
To test the effects of the use of a collapsible, portable chair (chair B), as opposed to a ‘standard’ chair (chair A), on the outcome of the timed “Up and Go” (TUG) test. 相似文献148.
149.
Background
Exercise has been recommended for improving global-well being in adults with fibromyalgia. However, no meta-analysis has determined the effects of exercise on global well-being using a single instrument and when analyzed separately according to intention-to-treat and per-protocol analyses. The purpose of this study was to fill that gap. 相似文献150.